Long-term local control and survival after preoperative radiochemotherapy in combination with deep regional hyperthermia in locally advanced rectal cancer

References

• Sauer R, Becker H, Hohenberger W, Rodel C, Wittekind C, Fietkau R, et al. Preoperative versus postoperative chemoradiotherapy for rectal cancer. N Engl J Med 2004;351:1731–40
   PubMed Web of Science ®Google Scholar
• Kapiteijn E, Marijnen CA, Nagtegaal ID, Putter H, Steup WH, Wiggers T, et al. Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer. N Engl J Med 2001;345:638–46
   PubMed Web of Science ®Google Scholar
• Overgaard J, Gonzalez Gonzalez D, Hulshof MC, Arcangeli G, Dahl O, Mella O, et al. Randomised trial of hyperthermia as adjuvant to radiotherapy for recurrent or metastatic malignant melanoma. European Society for Hyperthermic Oncology. Lancet 1995;345(8949):540–3
   PubMed Web of Science ®Google Scholar
• van der Zee J, Gonzalez Gonzalez D, van Rhoon GC, van Dijk JD, van Putten WL, Hart AA. Comparison of radiotherapy alone with radiotherapy plus hyperthermia in locally advanced pelvic tumours: A prospective, randomised, multicentre trial. Dutch Deep Hyperthermia Group. Lancet 2000;355(9210):1119–25
   PubMed Web of Science ®Google Scholar
• Jones EL, Oleson JR, Prosnitz LR, Samulski TV, Vujaskovic Z, Yu D, et al. Randomized trial of hyperthermia and radiation for superficial tumors. J Clin Oncol 2005;23:3079–85
   PubMed Web of Science ®Google Scholar
• Hildebrandt B, Wust P. The biologic rationale of hyperthermia. Cancer Treat Res 2007;134:171–84
   PubMedGoogle Scholar
• Dieing A, Ahlers O, Hildebrandt B, Kerner T, Tamm I, Possinger K, et al. The effect of induced hyperthermia on the immune system. Prog Brain Res 2007;162:137–52
   PubMed Web of Science ®Google Scholar
• Toraya-Brown S, Fiering S. Local tumour hyperthermia as immunotherapy for metastatic cancer. Int J Hyperthermia 2014;30(8):531–9
   PubMed Web of Science ®Google Scholar
• Ihara M, Takeshita S, Okaichi K, Okumura Y, Ohnishi T. Heat exposure enhances radiosensitivity by depressing DNA-PK kinase activity during double strand break repair. Int J Hyperthermia 2014;30:102–9
   PubMed Web of Science ®Google Scholar
• Asao T, Sakurai H, Harashima K, Yamaguchi S, Tsutsumi S, Nonaka T, et al. The synchronization of chemotherapy to circadian rhythms and irradiation in pre-operative chemoradiation therapy with hyperthermia for local advanced rectal cancer. Int J Hyperthermia 2006;22:399–406
   PubMed Web of Science ®Google Scholar
• Anscher MS, Lee C, Hurwitz H, Tyler D, Prosnitz LR, Jowell P, et al. A pilot study of preoperative continuous infusion 5-fluorouracil, external microwave hyperthermia, and external beam radiotherapy for treatment of locally advanced, unresectable, or recurrent rectal cancer. Int J Radiat Oncol Biol Phys 2000;47:719–24
   PubMed Web of Science ®Google Scholar
• Rau B, Wust P, Hohenberger P, Loffel J, Hunerbein M, Below C, et al. Preoperative hyperthermia combined with radiochemotherapy in locally advanced rectal cancer: A phase II clinical trial. Ann Surg 1998;227:380–9
   PubMed Web of Science ®Google Scholar
• Schroeder C, Gani C, Lamprecht U, von Weyhern CH, Weinmann M, Bamberg M, et al. Pathological complete response and sphincter-sparing surgery after neoadjuvant radiochemotherapy with regional hyperthermia for locally advanced rectal cancer compared with radiochemotherapy alone. Int J Hyperthermia 2012;28:707–14
   PubMed Web of Science ®Google Scholar
• Maas M, Nelemans PJ, Valentini V, Das P, Rodel C, Kuo LJ, et al. Long-term outcome in patients with a pathological complete response after chemoradiation for rectal cancer: A pooled analysis of individual patient data. Lancet Oncol 2010;11:835–44
   PubMed Web of Science ®Google Scholar
• Valentini V, van Stiphout RG, Lammering G, Gambacorta MA, Barba MC, Bebenek M, et al. Selection of appropriate end-points (pCR vs 2yDFS) for tailoring treatments with prediction models in locally advanced rectal cancer. Radiother Oncol 2015;114:302–9
   PubMed Web of Science ®Google Scholar
• Bosset JF, Collette L, Calais G, Mineur L, Maingon P, Radosevic-Jelic L, et al. Chemotherapy with preoperative radiotherapy in rectal cancer. N Engl J Med 2006;355:1114–23
   PubMed Web of Science ®Google Scholar
• Rau B, Wust P, Tilly W, Gellermann J, Harder C, Riess H, et al. Preoperative radiochemotherapy in locally advanced or recurrent rectal cancer: Regional radiofrequency hyperthermia correlates with clinical parameters. Int J Radiat Oncol Biol Phys. 2000;48:381–91
   PubMed Web of Science ®Google Scholar
• Kang MK, Kim MS, Kim JH. Clinical outcomes of mild hyperthermia for locally advanced rectal cancer treated with preoperative radiochemotherapy. Int J Hyperthermia 2011;27:482–90
   PubMed Web of Science ®Google Scholar
• Barsukov YA, Gordeyev SS, Tkachev SI, Fedyanin MY, Perevoshikov AG. Phase II study of concomitant chemoradiotherapy with local hyperthermia and metronidazole for locally advanced fixed rectal cancer. Colorectal Dis 2013;15:1107–14
   PubMed Web of Science ®Google Scholar
• Rau B, Hohenberger P, Gellermann J, Hunerbein M, Hildebrandt B, Schneider U, et al. [T4 rectal carcinoma. Surgical and multimodal therapy]. Chirurg; Zeitschrift fur alle Gebiete der operativen Medizen. 2002;73:147–53
   PubMed Web of Science ®Google Scholar
• De Haas-Kock DF, Buijsen J, Pijls-Johannesma M, Lutgens L, Lammering G, van Mastrigt GA, et al. Concomitant hyperthermia and radiation therapy for treating locally advanced rectal cancer. Cochrane Database Syst Rev 2009;8:CD006269
   Google Scholar
• Fokas E, Liersch T, Fietkau R, Hohenberger W, Beissbarth T, Hess C, et al. Tumor regression grading after preoperative chemoradiotherapy for locally advanced rectal carcinoma revisited: Updated results of the CAO/ARO/AIO-94 trial. J Clin Oncol 2014;32:1554–62
   PubMed Web of Science ®Google Scholar
• Schaffer M, Krych M, Pachmann S, Abdel-Rahman S, Schaffer PM, Ertl-Wagner B, et al. Feasibility and morbidity of combined hyperthermia and radiochemotherapy in recurrent rectal cancer – preliminary results. Onkologie 2003;26:120–4
   PubMedGoogle Scholar
• Milani V, Pazos M, Issels RD, Buecklein V, Rahman S, Tschoep K, et al. Radiochemotherapy in combination with regional hyperthermia in preirradiated patients with recurrent rectal cancer. Strahlenther Onkol 2008;184:163–8
   PubMed Web of Science ®Google Scholar
• Preoperative Radiochemotherapy With Hyperthermia for Locally Advanced Rectal Cancer (HT01). Clinical trial. Available from: https://clinicaltrials.gov/ct2/show/NCT02353858
   Google Scholar
• Rödel C, Graeven U, Fietkau R, Hohenberger W, Hothorn T, Arnold D, et al. Oxaliplatin added to fluorouracil-based preoperative chemoradiotherapy and postoperative chemotherapy of locally advanced rectal cancer (the German CAO/ARO/AIO-04 study): final results of the multicentre, open-label, randomised, phase 3 trial. Lancet Oncol 2015;16:979–89
   PubMed Web of Science ®Google Scholar
• Neoadjuvant chemoradiation with 5-FU(or capecitabine) and oxaliplatin combined with hyperthermia in rectal cancer (HyRec). Available from https://clinicaltrials.gov/ct2/show/NCT01716949
   Google Scholar
• Griffin RJ, Dings RP, Jamshidi-Parsian A, Song CW. Mild temperature hyperthermia and radiation therapy: Role of tumour vascular thermotolerance and relevant physiological factors. Int J Hyperthermia 2010;26:256–63
   PubMed Web of Science ®Google Scholar
• Zips D, Zophel K, Abolmaali N, Perrin R, Abramyuk A, Haase R, et al. Exploratory prospective trial of hypoxia-specific PET imaging during radiochemotherapy in patients with locally advanced head-and-neck cancer. Radioth Oncol 2012;105:21–8
   PubMed Web of Science ®Google Scholar